|
2008-10-16 |
FASECU I |
CIGB |
Registered |
|
2010-12-28 |
InCarbacel-II |
CIGB |
Registered |
|
2009-02-11 |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
CIGB |
Registered |
|
2009-02-11 |
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. |
CIGB |
Registered |
|
2009-02-11 |
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
CIGB |
Registered |
|
2009-12-11 |
THERESA-3 Study |
CIGB |
Registered |
|
2010-09-27 |
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
CIGB |
Registered |
|
2013-05-16 |
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study) |
CIGB |
Registered |
|
2013-06-06 |
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) |
CIGB |
Registered |
|
22/08/2013 |
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) |
CIGB |
Registered |
|
12/11/2021 |
BACONAO Study |
CIGB |
Registered outdated |
|
26/10/2021 |
VISION Study |
CIGB |
Registered |
|
14/11/2014 |
Study in Hematological Malignancies |
CIGB |
Registered |
|
16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
|
23/04/2014 |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
CIGB |
Registered |
|
10/11/2014 |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
CIGB |
Registered |
|
14/04/2020 |
ESPERANZA study |
CIGB |
Registered outdated |
|
08/04/2015 |
THERESA-5 Study |
CIGB |
Registered |
|
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
|
13/04/2020 |
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
CIGB |
Registered outdated |
